Center for Neutron Research, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA.
Section on Molecular Transport, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
Biochim Biophys Acta Biomembr. 2021 Sep 1;1863(9):183643. doi: 10.1016/j.bbamem.2021.183643. Epub 2021 May 7.
Regulation of VDAC by α-synuclein (αSyn) is a rich and instructive example of protein-protein interactions catalyzed by a lipid membrane surface. αSyn, a peripheral membrane protein involved in Parkinson's disease pathology, is known to bind to membranes in a transient manner. αSyn's negatively charged C-terminal domain is then available to be electromechanically trapped by the VDAC β-barrel, a process that is observed in vitro as the reversible reduction of ion flow through a single voltage-biased VDAC nanopore. Binding of αSyn to the lipid bilayer is a prerequisite of the channel-protein interaction; surprisingly, however, we find that the strength of αSyn binding to the membrane does not correlate in any simple way with its efficiency of blocking VDAC, suggesting that the lipid-dependent conformations of the membrane-bound αSyn control the interaction. Quantitative models of the free energy landscape governing the capture and release processes allow us to discriminate between several αSyn (sub-) conformations on the membrane surface. These results, combined with known structural features of αSyn on anionic lipid membranes, point to a model in which the lipid composition determines the fraction of αSyn molecules for which the charged C terminal domain is constrained to be close, but not tightly bound, to the membrane surface and thus readily captured by the VDAC nanopore. We speculate that changes in the mitochondrial membrane lipid composition may be key regulators of the αSyn-VDAC interaction and consequently of VDAC-facilitated transport of ions and metabolites in and out of mitochondria and, i.e. mitochondrial metabolism.
α-突触核蛋白(αSyn)对电压门控通道蛋白 1(VDAC1)的调节作用是一个丰富而有启发性的蛋白-蛋白相互作用的范例,这种相互作用由脂质膜表面催化。αSyn 是一种与帕金森病发病机制有关的外周膜蛋白,已知其以瞬时方式与膜结合。αSyn 的带负电荷的 C 端结构域随后可被 VDAC1β-桶以电机械方式捕获,这一过程在体外表现为通过单个加偏压的 VDAC1 纳米孔的离子流可逆性降低。αSyn 与双层脂膜的结合是通道-蛋白相互作用的前提;然而,令人惊讶的是,我们发现 αSyn 与膜的结合强度与其阻断 VDAC1 的效率没有简单的相关性,这表明膜结合的 αSyn 的脂质依赖性构象控制着相互作用。控制捕获和释放过程的自由能景观的定量模型使我们能够区分膜表面上的几种 αSyn(亚)构象。这些结果与阴离子脂质膜上已知的 αSyn 结构特征相结合,表明这样一种模型:脂质组成决定了αSyn 分子的一部分,对于这些分子来说,带电荷的 C 端结构域被约束在靠近但不紧密结合到膜表面的位置,从而可被 VDAC1 纳米孔轻易捕获。我们推测,线粒体膜脂质组成的变化可能是 αSyn-VDAC1 相互作用以及因此 VDAC1 促进离子和代谢物进出线粒体的转运的关键调节剂,即线粒体代谢。